Relafen Naproxium 750, viewed analyzed from a biochemical pharmaceutical pharmacy perspective, represents a compelling significant illustration of NSAID or non-copyrightal anti-inflammatory drug action. Its mechanism or mode involves primarily or mainly inhibiting cyclooxygenase enzymes, specifically COX-2, thereby reducing lowering the production